ANTARES PHARMA INC's ticker is and the CUSIP is 036642956. A total of 3 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | +64.3% | 5,800 | +38.1% | 0.00% | – |
| Q4 2021 | $14,000 | -88.9% | 4,200 | -85.5% | 0.00% | – |
| Q3 2021 | $126,000 | 0.0% | 28,900 | 0.0% | 0.00% | – |
| Q2 2021 | $126,000 | -39.4% | 28,900 | +5589.0% | 0.00% | – |
| Q1 2021 | $208,000 | -40.9% | 508 | -42.5% | 0.00% | – |
| Q4 2020 | $352,000 | +67.6% | 884 | +13.5% | 0.00% | – |
| Q3 2020 | $210,000 | +366.7% | 779 | +366.5% | 0.00% | – |
| Q2 2020 | $45,000 | -33.8% | 167 | -42.8% | 0.00% | – |
| Q1 2020 | $68,000 | -88.5% | 292 | -76.8% | 0.00% | -100.0% |
| Q4 2019 | $592,000 | +51.8% | 1,260 | +8.1% | 0.00% | 0.0% |
| Q3 2019 | $390,000 | +59.8% | 1,166 | +56.7% | 0.00% | 0.0% |
| Q2 2019 | $244,000 | -29.7% | 744 | -35.1% | 0.00% | 0.0% |
| Q1 2019 | $347,000 | +57.7% | 1,147 | +41.3% | 0.00% | 0.0% |
| Q4 2018 | $220,000 | +243.8% | 812 | +322.9% | 0.00% | – |
| Q3 2018 | $64,000 | +137.0% | 192 | +81.1% | 0.00% | – |
| Q2 2018 | $27,000 | +440.0% | 106 | +1.9% | 0.00% | – |
| Q1 2018 | $5,000 | – | 104 | +940.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | +100.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | -92.9% | 0.00% | – |
| Q1 2017 | $0 | – | 70 | +1300.0% | 0.00% | – |
| Q3 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 16,400 | $45,000 | 0.00% |
| SIMPLEX TRADING, LLC | 167 | $45,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |